Options for Regenerative Therapy in the Field of Breast Surgery

被引:9
|
作者
Prantl, L. [1 ]
Heine, N. [1 ]
机构
[1] Univ Regensburg, Ctr Plast & Aesthet Hand & Reconstruct Surg, D-93042 Regensburg, Germany
关键词
breast reconstruction; tissue engineering; liposuction; experimental transplantations; ADIPOSE-TISSUE GENERATION; AUTOLOGOUS FAT TRANSFER; DE-NOVO GENERATION; STEM-CELLS; IN-VITRO; GELATIN MICROSPHERES; CAPSULAR CONTRACTURE; COLLAGEN SCAFFOLDS; LONG-TERM; DIFFERENTIATION;
D O I
10.1055/s-0031-1297966
中图分类号
R61 [外科手术学];
学科分类号
摘要
Besides the established techniques of pediculed and free tissue transplantations for breast reconstruction, adipose tissue engineering and structural fat grafting are being applied as options for regenerative therapy. While the initial euphoria about the foreseeable realisation of cell-matrix entities of sufficient size, functionality and long-term volume stability for use in humans has diminished somewhat, fat grafting as experienced a renaissance in recent years. One of the decisive factors for the engraftment of the tissue graft generated though tissue engineering is the formation of an adequate vascular network. Improvements of the matrix, which ideally should mimic natural tissue, such as the use of adipose-derived stem cells (ASCs) that can contribute both to adipogenesis and neoangiogenesis represent promising new approaches. In autologous fat grafting, the mixing of adipocytes and cells of the stromal-vascular fraction (SVF) in order to generate the principle of an inductive microenvironment has already been applied successfully in clinical routine. On the basis of the experimental data that demonstrate an interaction of the adipocytes, ASCs and other progenitor cells with breast cancer cells and the insufficient clinical data regarding oncological safety, this procedure should only be used critically. A concluding evaluation will only be possible after long-term clinical studies have provided good results.
引用
收藏
页码:103 / 111
页数:9
相关论文
共 50 条
  • [41] Biohybrid polymers: novel options for regenerative therapies
    Werner, C.
    EXPRESS POLYMER LETTERS, 2007, 1 (06): : 333 - 333
  • [42] Basement of matrix therapy in regenerative medicine by RGTA® : From fundamental to plastic surgery
    Barritault, D.
    Garcia-Filipe, S.
    Zakine, G.
    ANNALES DE CHIRURGIE PLASTIQUE ESTHETIQUE, 2010, 55 (05): : 413 - 420
  • [43] LIMITED SURGERY IN THE THERAPY OF BREAST-CANCER
    RAUSCHECKER, H
    SCHAUER, A
    BECKER, HD
    PEIPER, HJ
    LANGENBECKS ARCHIV FUR CHIRURGIE, 1983, 361 : 775 - 775
  • [44] SURGERY AS AN ADJUNCT TO HORMONE THERAPY OF BREAST CANCER
    KENNEDY, BJ
    KELLEY, RM
    WHITE, G
    NATHANSON, IT
    CANCER, 1957, 10 (05) : 1055 - 1075
  • [45] Breast surgery after neoadjuvant systemic therapy
    Pawloski, Kate R.
    Barrio, Andrea, V
    TRANSLATIONAL BREAST CANCER RESEARCH, 2024, 5
  • [46] Overcoming the Restricted Therapy Options and Monitoring Challenges in Metastatic Breast Cancer
    Aliyev, A. Tascioglu
    Krager, K.
    LoBianco, F.
    Ozbilgin, K.
    Ucoz, M.
    Aykin-Burns, N.
    Gurer-Orhan, H.
    TOXICOLOGY LETTERS, 2021, 350 : S155 - S155
  • [47] Systemic therapy options in BRCA mutation-associated breast cancer
    Soley Bayraktar
    Stefan Glück
    Breast Cancer Research and Treatment, 2012, 135 : 355 - 366
  • [48] Complication and economic burden of local therapy options for early breast cancer
    Smith, B. D.
    Jiang, J.
    Shih, Y-C T.
    Giordano, S. H.
    Huo, J.
    Jagsi, R.
    Caudle, A. S.
    Hunt, K. K.
    Shaitelman, S. F.
    Buchholz, T. A.
    Shirvani, S. M.
    CANCER RESEARCH, 2016, 76
  • [49] Adjuvant endocrine therapy options in hormone-dependent breast cancer
    Strasser-Weippl, K
    Goss, PE
    EJC SUPPLEMENTS, 2005, 3 (03): : 247 - 254
  • [50] Systemic therapy options in BRCA mutation-associated breast cancer
    Bayraktar, Soley
    Glueck, Stefan
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 135 (02) : 355 - 366